Deutsche Bank
ENFN

Deutsche Bank’s Enfusion, Inc. ENFN Stock Holding History

Deutsche Bank’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62,611
Closed -$698K – 3780
2025
Q1 		$698K Sell
62,611
-4,461
-7% -$49.3K ﹤0.01% 2327
2024
Q4 		$691K Buy
67,072
+39,004
+139% +$377K ﹤0.01% 2452
2024
Q3 		$266K Buy
28,068
+9,654
+52% +$83.3K ﹤0.01% 2778
2024
Q2 		$157K Buy
18,414
+2,704
+17% +$24.7K ﹤0.01% 2942
2024
Q1 		$145K Sell
15,710
-370
-2% -$3.26K ﹤0.01% 2999
2023
Q4 		$156K Buy
16,080
+3,587
+29% +$33.5K ﹤0.01% 3002
2023
Q3 		$112K Buy
12,493
+918
+8% +$8.72K ﹤0.01% 3110
2023
Q2 		$130K Sell
11,575
-5,253
-31% -$46.6K ﹤0.01% 3134
2023
Q1 		$177K Buy
16,828
+4,292
+34% +$47.3K ﹤0.01% 3071
2022
Q4 		$121K Buy
12,536
+172
+1% +$1.94K ﹤0.01% 3239
2022
Q3 		$152K Sell
12,364
-1,701
-12% -$20.8K ﹤0.01% 3110
2022
Q2 		$144K Buy
14,065
+1,659
+13% +$18.3K ﹤0.01% 3345
2022
Q1 		$157K Sell
12,406
-1,398
-10% -$21.4K ﹤0.01% 3389
2021
Q4 		$289K Buy
+13,804
New +$279K ﹤0.01% 3171

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deutsche Bank's ENFN Position: Q2 2025 in Review

Deutsche Bank sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 62,611 shares — an estimated $698K sold.

Deutsche Bank first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $698K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Deutsche Bank reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 62,611 Enfusion, Inc. shares in Q2 2025, an estimated $698K.
  • Deutsche Bank first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Deutsche Bank's Enfusion, Inc. position peaked at $698K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.